Why Hospitals Need to Focus More on Personalize and Customize Precision Treatment in Oncology? - Dr Manoj Lokhande

Published On 2024-07-16 09:53 GMT | Update On 2024-07-16 09:53 GMT

Offering tailor-made treatment for patients will bring a revolutionary change and successful prognosis of cancer. This article highlights the role of customized treatment plans in improving the quality of life of cancer patients.

Currently, the healthcare sector is evolving rapidly owing to the help of cutting-edge technology. The emerging concept of personalized and customized precision treatment is like a game-changer in the field of oncology that can be beneficial in various ways and help save lives.

By considering certain factors such as genetics and lifestyle habits, doctors can provide effective treatments that fit each patient's medical needs. This ensures that the treatments work successfully by making healthcare more effective and giving hope for a better future.

This is how a tailor-made treatment plan can improve the patient's outcome:

Personalized precision treatment helps patients acquire top-notch treatment for diagnosing cancer with innovative and advanced technologies increasing positive outcomes. With advancements in technology such as genomic sequencing and targeted therapy options, it is now possible to offer cutting-edge cancer treatments that are customized and customized while considering various factors and addressing each patient's unique needs. This revolutionary shift is essential for an individualized approach and is crucial for ensuring that the quality of life for cancer patients is enhanced with the best possible care.

The personalized treatment can help create precise and tailored therapies that significantly improve quality of life and also increase survival rate, which can encourage and reassure cancer patients. With this approach, unnecessary healthcare costs are reduced as the treatment plan is tailored based on genetic mutation, biomarkers, and limiting trial-and-error approaches resulting in successful outcomes. The plan is made considering essential factors such as what makes your cancer grow, the type of cancer, and its genetic makeup. This customized remedy enables crafting a powerful diagnosis and effective treatment, compared to the one-size-suits-all approach.

New technologies like next-generation sequencing have created revolutionary changes by allowing doctors to do in-depth study and research about vast amounts of genomic data. This deeper and more detailed understanding of tumours has led to the creation of targeted therapies. These therapies are specifically designed in a way to directly attack cancer cells based on their genetic profile while saving healthy cells. This personalized approach increases the chances of better outcomes and responses to the treatment, meaning it is possible to shrink the growth of cancer. As a result, the success and survival rates increase while improving the quality of life.

Moreover, the integration of AI (Artificial intelligence) and machine learning algorithms has become an essential part of crafting personalized cancer treatment plans. These advanced tools help doctors understand and analyse vast amounts of data to make informed decisions about the best treatment option for each patient. By using AI, health providers can identify patterns and decide which treatments are most likely to be more effective, while ensuring that each patient receives the best possible care.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr Manoj Lokhande

Dr Manoj Lokhande (MBBS, MS, FMAS, FIAGES) is a Surgical Oncologist at Onco life cancer center, Satara. Dr. Manoj Lokhande has completed his Surgical Oncology from TATA Memorial Hospital, Mumbai. He heads the Surgical Oncology Department and also is a part of the Board of Directors at Onco-Life Cancer Centre. He specializes in all types of Onco Surgeries and has a vast experience in this field. Dr Lokhande has performed over 10,000 surgeries so far. He is a member of the Indian Association of Surgical Oncology. He has completed his fellowship IACA Hepatobiliary Cancers from Illinois, Chicago, USA and Cancer Epidemiology, IARC, LYON France, WHO, Europe.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Why Hospitals Need to Focus More on Personalize and Customize Precision Treatment in Oncology? - Dr Manoj Lokhande

Similar News

Do people with multiple sclerosis have an increased risk of cancer?

Harmonizing Adult Vaccination Guidelines in India: Need of the Hour

Ten Recent Landmark Trials Across Oncology - Dr Vidit Kapoor

Safety of Ranitidine: A Fresh Look at an Old Gem

Long-term PPI Use and Increased Cancer Risk: An Unrevealed Truth

Countering Post-operative Wound Inflammation with Trypsin-Bromelain-Rutoside Combination

Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial